The target trial emulation study suggests rigid risk thresholds aren’t needed to steer statin use in this group.

Findings of reduced risks for mortality and major CVD suggest consideration of statins in all adults with type 2 diabetes, even in those with low short-term predicted CVD risk.

When the American College of Cardiology/American Heart Association (ACC/AHA) released new cholesterol guidelines in 2013, replacing older guidelines and changing statin eligibility, more patients with ...

Hoping to prevent coronary heart disease, doctors issued aggressive new guidelines Tuesday that could nearly triple the number of Americans taking drugs to lower their cholesterol. The guidelines, ...

The guidelines advocate for more aggressive treatment with statin therapy. Heart disease is the leading cause of death in the U.S. The American Heart Association and the American College of Cardiology ...

Under current national cholesterol guidelines, only half of younger patients who experience an MI would have been identified as being at high risk and eligible for treatment with lipid-lowering ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — New cholesterol guidelines from the American Heart Association, American College of Cardiology and 10 ...

The guidelines, published Saturday in the journal Circulation, are meant to help health care providers prevent, diagnose and treat high cholesterol. A panel of 24 science and health experts from the ...

The guidelines unveiled at the American Heart Association annual meeting discuss when patients at the highest risk could be treated with a PCSK9 inhibitor. Nearly 1 in 3 Americans have high levels of ...

CHARLESTON, SC – Just last November, the American College of Cardiology (ACC) and American Heart Association (AHA) published new clinical guidelines for the management of cholesterol, and the ...

New cholesterol guidelines recommend a more personalized approach in risk assessments, a returned focus on LDL target levels and new drug options for those at highest risk for cardiovascular disease.